Use of a locked-nucleic-acid oligomer in the clamped-probe assay for detection of a minority Pfcrt K76T mutant population of Plasmodium falciparum

Journal of Clinical Microbiology

Volumn 43, Issue 7, 2005, Pages 3304-3308

  Senescau, Alice ^a   Berry, Antoine ^a   Benoit Vical, Françoise ^a,b   Landt, Olfert ^c   Fabre, Richard ^a   Lelièvre, Joël ^a,b   Cassaing, Sophie ^a   Magnaval, Jean François ^a  

^a CHU RANGUEIL   (France)

^b LCC LABORATOIRE DE CHIMIE DE COORDINATION   (France)

^c TIB MOLBIOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LOCKED NUCLEIC ACID; LYSINE; OLIGOMER; THREONINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CLAMPED PROBE ASSAY; CLONAL VARIATION; CONTROLLED STUDY; GENE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MELTING POINT; MOLECULAR PROBE; NONHUMAN; PARASITE IDENTIFICATION; PFCRT GENE; PLASMODIUM FALCIPARUM; POPULATION GENETICS; PRIORITY JOURNAL; PROTOZOAL INFECTION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; CODON; DNA, PROTOZOAN; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MUTATION; PARASITIC SENSITIVITY TESTS; PEPTIDE NUCLEIC ACIDS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

PLASMODIUM FALCIPARUM;

EID: 22144453923     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.7.3304-3308.2005     Document Type: Article

References (27)

1. Basco, L. K., and P. Ringwald. 2001. Analysis of the key Pfcrt point mutation and in vitro and in vivo response to chloroquine in Yaoundé, Cameroon. J. Infect. Dis. 183:1828-1831.
2. Braasch, D. A., and D. R. Corey. 2000. Locked nucleic acid (LNA): fine tuning the recognition of DNA and RNA. Chem. Biol. 55:1-7.
3. Chen, C. Y., S. C. Shiesh, and S. J. Wu. 2004. Rapid detection of k-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis. Clin. Chem. 50:481-489.
4. Conway, D. J., B. M. Greenwood, and J. S. McBride. 1991. The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients. Parasitology 103(Pt. 1):1-6.
5. Esaki, H., K. Noda, N. Otsuki, A. Kojima, T. Asai, Y. Tamura, and T. Takahashi. 2004. Rapid detection of quinolone-resistant Salmonella by real-time SNP genotyping. J. Microbiol. Methods 58:131-134.
6. Fabre, R., A. Berry, B. Morassin, and J. F. Magnaval. 2004. Comparative assessment of conventional PCR with multiplex real-time PCR using SYBR Green I detection for the molecular diagnosis of imported malaria. Parasitology 128(Pt. 1):15-21.
7. Fidock, D. A., T. Nomura, A. K. Talley, A. R. Cooper, M. S. Dzekunov, T. M. Ferdig, M. L. Ursos, A. B. Sidhu, B. Naude, W. K. Deitsh, Z. X. Su, C. J. Wootton, D. P. Roepe, and E. T. Wellems. 2000. Mutations in the Plasmodium falciparum digestive vacuole transmembrane protein Pfcrt and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
8. Hance, A. J., V. Lemiale, J. Izopet, D. Lecossier, V. Joly, P. Massip, F. Mammano, D. Descamps, F. Brun-Vezinet, and F. Clavel. 2001. Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J. Virol. 75:6410-6417.
9. Izopet, J., C. Souyris, A. Hance, K. Sandres-Saunes, M. Alvarez, C. Pasquier, F. Clavel, J. Puel, and P. Massip. 2002. Evolution of human immunodeficiency virus type 1 populations after resumption of therapy following treatment interruption and shift in resistance genotype. J. Infect. Dis. 185: 1506-1510.
10. Jafari, S., J. Le Bras, O. Bouchaud, and R. Durand. 2004. Plasmodium falciparum clonal population dynamics during malaria treatment. J. Infect. Dis. 189:195-203.
11. Johnson, M. P., L. M. Haupt, and L. R. Griffiths. 2004. Locked nucleic acid (LNA) single nucleotide polymorphism (SNP) genotype analysis and validation using real-time PCR. Nucleic Acids Res. 32:e55.
12. Kapoor, A., M. Jones, R. W. Shafer, S. Y. Rhee, P. Kazanjian, and E. L. Delwart. 2004. Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay. J. Virol. 78:7112-7123.
13. Koshkin, A. A., S. K. Singh, P. Nielsen, V. K. Rajwanshi, R. Kumar, M. Meldgaard, C. E. Olsen, and J. Wengel. 1998. LNA (locked nucleic acid): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine, and uracil bicyclonucleoside monomers, oliomerisation, and unprecedented nucleic acid recognition. Tetrahedron 54:3607-3630.
14. Kreuzer, K. A., P. le Coutre, O. Landt, L. K. Na, M. Schwarz, K. Shultheis, A. Hochhaus, and B. Dörken. 2003. Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique. Ann. Hematol. 82:284-289.
15. Kublin, J. G., J. F. Cortese, E. M. Njunju, R. A. Mukadam, J. J. Wirima, P. N. Kazembe, A. A. Djimde, B. Kouriba, T. E. Taylor, and C. V. Plowe. 2003. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J. Infect. Dis. 187:1870-1875.
16. Latorra, D., K. Campbell, A. Wolter, and J. M. Hurley. 2003. Enhanced allele-specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers. Hum. Mutat. 22:79-85.
17. Lok, A. S., F. Zoulim, S. Locarnini, A. Mangia, G. Niro, H. Decraemer, G. Maertens, F. Hulstaert, K. De Vreese, and E. Sablon. 2002. Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay. J. Clin. Microbiol. 40:3729-3734.
18. Mayxay, M., P. N. Newton, M. Khanthavong, P. Tienjjkham, R. Phetsouvanh, S. Phompida, A. Brockman, and N. J. White. 2003. Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Laos People's Democratic Republic: an assessment of national antimalarial drug recommendations. Clin. Infect. Dis. 37: 1021-1028.
19. Mohn, S. C., A. Ulvik, R. Jureen, J. L. Willems, J. Top, H. Leavis, S. Harthug, and N. Langeland. 2004. Duplex real-time PCR assay for rapid detection of ampicillin-resistant Enterococcus faecium. Antimicrob. Agents Chemother. 48:556-560.
20. Moyle, G. J. 1997. Current knowledge of HIV-1 reverse transcriptase mutations selected during nucleoside analogue therapy: the potential to use resistance data to guide clinical decisions. J. Antimicrob. Chemother. 40:765-777.
21. Nguyen, M. H., T. M. Davis, J. Cox-Singh, S. Hewitt, Q. T. Tran, T. H. Nguyen, N. P. Vo, H. N. Doan, and D. C. Le. 2003. Treatment of uncomplicated falciparum malaria in southern Vietnam: can chloioquine or sulfadoxine- pyrimethamine be reintroduced in combination with artesunate? Clin. Infect. Dis. 37:1461-1464.
22. Patterson, J. E., A. H. Sweeney, M. Simms, N. Carley, R. Mangi, J. Sabetta, and R. W. Lyons. 1995. An analysis of 110 serious enterococcal infections: epidemiology, antibiotic, susceptibility, and outcome. Medicine 74:1480-1486.
23. Rolain, J. M., M. N. Mallet, P. E. Fournier, and D. Raoult. 2004. Real-time PCR for universal antibiotic susceptibility testing. J. Antimicrob. Chemother. 54:538-541.
24. Vessiere, A., A. Berry, R. Fabre, F. Benoit-Vical, and J. F. Magnaval. 2004. Detection by real-time PCR of the Pfcrt T76 mutation, a molecular marker of chloroquine-resistant Plasmodium falciparum strains. Parasitol. Res. 93: 5-7.
25. Walling, D. M., L. A. Andritsos, W. Etienne, D. A. Payne, J. F. Aronson, C. M. Flaitz, and C. M. Nichols. 2004. Molecular markers of clonality and identity in Epstein-Barr virus-associated B-cell lymphoproliferative disease. J. Med. Virol. 74:94-101.
26. Wellems, T. E., and C. V. Plowe. 2001. Chloroquine resistant malaria. J. Infect. Dis. 184:770-776.
27. Wendt, C., S. A. Messer, R. J. Hollis, M. A. Pfaller, and L. A. Herwaldt. 1998. Epidemiology of polyclonal gram-negative bacteremia. Diagn. Microbiol. Infect. Dis. 32:9-13.